Faruk Çukurovalı | Didim Nokta Atışı Enjeksiyon & Nöral Terapi. BEL ve BOYUN FITIĞI, KALÇA ve DİZ tedavisi
farukcukurovali.com.tr
LaunchIndex first observed Faruk Çukurovalı | Didim Nokta Atışı Enjeksiyon & Nöral Terapi. BEL ve BOYUN FITIĞI, KALÇA ve DİZ tedavisi (farukcukurovali.com.tr) live on 1 September 2026. View its launch screenshot, category, and verification evidence.
A launch record built from evidence.
Faruk Çukurovalı | Didim Nokta Atışı Enjeksiyon & Nöral Terapi. BEL ve BOYUN FITIĞI, KALÇA ve DİZ tedavisi (farukcukurovali.com.tr) was first observed live on 1 September 2026.
Medical clinic in Didim, Aydın offering targeted subcutaneous injection therapy, neural therapy, and treatments for painful joints (back, hip, knee) with personalized assessment and care.
Its profile is classified as Local business within Health / Health and wellness.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- farukcukurovali.com.tr
- Category
- Health / Health and wellness
- Website type
- Local business
- Observed title
- Faruk Çukurovalı | Didim Nokta Atışı Enjeksiyon & Nöral Terapi. BEL ve BOYUN FITIĞI, KALÇA ve DİZ tedavisi
- Observed description
- Faruk Çukurovalı, Didim/Aydın'da nokta atışı ile deri altı enjeksiyon tedavisi, nöral terapi,BEL ve BOYUN FITIĞI KALÇA,DİZ. ağrılı eklem tedavisi ve topuk dikeni şikâyetlerinde bilgilendirme sunar.
- Detected technologies
- None detected
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 93%
- HTTP status
- 200
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.